Insider and congress filings
West Pharmaceutical Services, Inc. (WST)
Free on iOS and Android.
About West Pharmaceutical Services, Inc.
from the company's filings and listing, as of Oct 22, 2026- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Chief executive
- Michel Lagarde
- Employees
- 10,800
- Listed since
- -
- Market value
- $27.7B
- Price to earnings (12 mo)
- 50.0
- Net income per share, as reported (12 mo)
- $7.98
- Dividend yield
- 0.22%
Earnings
6 reported quarters · next on Oct 29, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Jul 23, 2026 | $2.37 | $2.08 | $872.3M | $840.0M | EPS beatRevenue beat |
| Q1 FY2026reported Apr 23, 2026 | $2.13 | $1.68 | $844.9M | $780.3M | EPS beatRevenue beat |
| Q4 FY2025reported Feb 12, 2026 | $2.04 | $1.83 | $805.0M | $794.9M | EPS beatRevenue in line |
| Q3 FY2025reported Oct 23, 2025 | $1.96 | $1.68 | $804.3M | $785.7M | EPS beatRevenue beat |
| Q2 FY2025reported Jul 24, 2025 | $1.84 | $1.51 | $766.2M | $726.1M | EPS beatRevenue beat |
| Q1 FY2025reported Apr 24, 2025 | $1.45 | $1.22 | $698.0M | $713.0M | EPS beatRevenue miss |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for fiscal 2025 · proxy filed Mar 12, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Robert W. McMahonSVP, Chief Financial Officer | $292K | $5.8M | $5.7M | $11.8M |
| Eric M. GreenPresident and CEO, Chair of Board | $1.2M | $3.3M | $2.7M | $7.2M |
| Shane A. CampbellSVP, Chief Proprietary Segment Officer | $369K | $1.2M | $841K | $2.4M |
| Annette F. FavoriteSVP, Chief Human Resources Officer | $450K | $343K | $597K | $1.4M |
The summary compensation table from the proxy statement for fiscal 2025, with titles as filed then. 2 executives who have since left the company are named in that filing and not shown here. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Shares vs prior qtr | % of shares out |
|---|---|---|---|---|
| BlackRock, Inc. | $2.4B | 6,651,784 | -2.7% | 9.40% |
| Vanguard Capital Management LLC | $1.7B | 4,613,134 | -1.5% | 6.52% |
| Vanguard Portfolio Management LLC | $1.4B | 4,015,766 | -1.9% | 5.67% |
| FMR LLC | $1.3B | 3,574,816 | +186.0% | 5.05% |
| State Street Corp | $1.2B | 3,348,698 | +1.7% | 4.73% |
| Artisan Partners Limited Partnership | $865.8M | 2,411,792 | -9.3% | 3.41% |
| Bank of New York Mellon Corp | $733.7M | 2,043,823 | -17.1% | 2.89% |
| Generation Investment Management LLP | $728.2M | 2,028,322 | -9.6% | 2.86% |
| Geode Capital Management, LLC | $680.6M | 1,903,279 | -0.5% | 2.69% |
| T. Rowe Price Investment Management, Inc. | $648.0M | 1,805,019 | -22.9% | 2.55% |
| Morgan Stanley | $568.1M | 1,582,546 | +8.5% | 2.24% |
| JPMorgan Chase & Co. | $413.0M | 1,164,527 | +11.6% | 1.64% |
A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Open-market insider trades
6 filings shown · newest filing first| Insider | Action | Shares | Price | Value | Trade date | Delay (business days) |
|---|---|---|---|---|---|---|
| Annette F. FavoriteSr. VP & Chief HR Officer | Sold · scheduled | 2,524 | $365.00 | $921K | Sep 15, 2026filed Sep 15, 2026 | 0d |
| Annette F. FavoriteSr. VP & Chief HR Officer | Sold · scheduled | 2,500 | $355.00 | $888K | Sep 14, 2026filed Sep 15, 2026 | 1d |
| Annette F. FavoriteSr. VP & Chief HR Officer | Sold · scheduled | 2,500 | $345.00 | $863K | Sep 11, 2026filed Sep 15, 2026 | 2d |
| Annette F. FavoriteSr. VP & Chief HR Officer | Sold | 2,500 | $340.81 | $852K | Sep 8, 2026filed Sep 10, 2026 | 2d |
| Chad WintersVP, Chief Accounting Officer | Sold | 896 | $300.67 | $269K | Apr 27, 2026filed Apr 29, 2026 | 2d |
| Annette F. FavoriteSr. VP & Chief HR Officer | Sold | 2,817 | $305.20 | $860K | Apr 27, 2026filed Apr 29, 2026 | 2d |
One row is one filing, newest filing first. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count. Scheduled: set up in advance under a Rule 10b5-1 trading plan. The delay counts business days from the trade to the filing, the unit of Form 4's two business day deadline: weekends and federal holidays are skipped. How the filing itself works is explained in our guide to Form 4.
Other Form 4 activity (20)
| Insider | Event | Shares | Date |
|---|---|---|---|
| Janet Brutschea HaugenDirector | Stock award | 44 | Sep 30, 2026 |
| Annette F. FavoriteSr. VP & Chief HR Officer | Option exercise | 2,500 | Sep 11, 2026 |
| Annette F. FavoriteSr. VP & Chief HR Officer | Option exercise | 2,524 | Sep 15, 2026 |
| Annette F. FavoriteSr. VP & Chief HR Officer | Option exercise | 2,500 | Sep 14, 2026 |
| Annette F. FavoriteSr. VP & Chief HR Officer | Option exercise | 8,135 | Sep 8, 2026 |
| Michel LagardePresident and CEO | Stock award | 51,798 | Sep 8, 2026 |
| Robert W. McMahonSVP & Chief Financial Officer | Tax withholding | 3,109 | Aug 11, 2026 |
| Robert W. McMahonSVP & Chief Financial Officer | Option exercise | 7,149 | Aug 11, 2026 |
| Janet Brutschea HaugenDirector | Stock award | 46 | Jun 30, 2026 |
| Shane Alden CampbellSVP, Proprietary Segment | Tax withholding | 219 | May 12, 2026 |
| Shane Alden CampbellSVP, Proprietary Segment | Option exercise | 770 | May 12, 2026 |
| Mark A. ButhmanDirector | Stock award | 791 | May 4, 2026 |
| William F. FeeheryDirector | Stock award | 791 | May 4, 2026 |
| Robert F. FrielDirector | Stock award | 791 | May 4, 2026 |
| Janet Brutschea HaugenDirector | Stock award | 791 | May 4, 2026 |
| Molly JosephDirector | Stock award | 791 | May 4, 2026 |
| Deborah L. KellerDirector | Stock award | 791 | May 4, 2026 |
| Goldman Myla LaiDirector | Stock award | 791 | May 4, 2026 |
| Stephen H. LockhartDirector | Stock award | 791 | May 4, 2026 |
| Douglas A. MichelsDirector | Stock award | 791 | May 4, 2026 |
Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.
Congress trades in WST
20 disclosures of 39 on record · median 30d of the 45 allowedSince the trade: the stock's move from its estimated entry price (a purchase) or estimated exit price (a sale) to its current price, the latest close we hold. Not the member's result.
| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +25.6% since the saleEstimated exit price $312.17, close on Tue Jun 2Current price $392.15, close on Fri Oct 23 | Jun 2, 2026 | Jul 6, 2026 | 34d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +25.4% since the saleEstimated exit price $312.71, close on Wed May 27Current price $392.15, close on Fri Oct 23 | May 27, 2026 | Jun 9, 2026 | 13d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +69.3% since the saleEstimated exit price $231.62, close on Thu Feb 5Current price $392.15, close on Fri Oct 23 | Feb 5, 2026 | Mar 9, 2026 | 32d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +68.6% since the tradeEstimated entry price $232.65, close on Thu Jan 29Current price $392.15, close on Fri Oct 23 | Jan 29, 2026 | Feb 6, 2026 | 8d |
| Lisa C. McClainSpouse | Stock | Purchase | $1,001 - $15,000 | +79.8% since the tradeEstimated entry price $218.06, close on Tue Jun 17, 2025Current price $392.15, close on Fri Oct 23 | Jun 17, 2025 | Aug 13, 2025 | 57d |
| Lisa C. McClainSpouse | Stock | Sale | $1,001 - $15,000 | +79.1% since the saleEstimated exit price $218.90, close on Tue Jul 22, 2025Current price $392.15, close on Fri Oct 23 | Jul 22, 2025 | Aug 13, 2025 | 22d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +80.5% since the tradeEstimated entry price $217.22, close on Mon May 19, 2025Current price $392.15, close on Fri Oct 23 | May 19, 2025 | Jun 10, 2025 | 22d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +79.7% since the tradeEstimated entry price $218.18, close on Wed Apr 23, 2025Current price $392.15, close on Fri Oct 23 | Apr 23, 2025 | May 12, 2025 | 19d |
| Robert Bresnahan | Stock | Sale | $1,001 - $15,000 | +106.0% since the saleEstimated exit price $190.39, close on Tue Apr 8, 2025Current price $392.15, close on Fri Oct 23 | Apr 8, 2025 | May 8, 2025 | 30d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +74.9% since the saleEstimated exit price $224.23, close on Wed Mar 12, 2025Current price $392.15, close on Fri Oct 23 | Mar 12, 2025 | Apr 10, 2025 | 29d |
| Robert Bresnahan | Stock | Purchase | $1,001 - $15,000 | +78.1% since the tradeEstimated entry price $220.15, close on Tue Feb 25, 2025Current price $392.15, close on Fri Oct 23 | Feb 25, 2025 | Mar 27, 2025 | 30d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +93.7% since the saleEstimated exit price $202.49, close on Wed Feb 19, 2025Current price $392.15, close on Fri Oct 23 | Feb 19, 2025 | Mar 6, 2025 | 15d |
| Jared MoskowitzDependent child | Stock | Sale | $1,001 - $15,000 | +97.0% since the saleEstimated exit price $199.11, close on Thu Feb 13, 2025Current price $392.15, close on Fri Oct 23 | Feb 13, 2025 | Mar 6, 2025 | 21d |
| Jared Moskowitz | Stock | Sale | $1,001 - $15,000 | +21.0% since the saleEstimated exit price $324.10, close on Fri Nov 8, 2024Current price $392.15, close on Fri Oct 23 | Nov 8, 2024 | Dec 9, 2024 | 31d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | n/a | Oct 11, 2024 | Nov 8, 2024 | 28d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | n/a | Oct 14, 2024 | Nov 8, 2024 | 25d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | n/a | Aug 2, 2024 | Sep 6, 2024 | 35d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | n/a | Aug 5, 2024 | Sep 6, 2024 | 32d |
| Jared Moskowitz | Stock | Purchase | $1,001 - $15,000 | n/a | Jul 14, 2023 | Aug 21, 2024 | 404d |
| Jared MoskowitzDependent child | Stock | Purchase | $1,001 - $15,000 | n/a | Dec 28, 2023 | Aug 21, 2024 | 237d |
Estimated prices are the stock's closing price on the trade date. A disclosure gives a value band, not the price paid. Not investment advice. After a sale a positive figure means the stock kept rising after it. On an option line the prices are the stock's, never the option's: the premium is never disclosed.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no prices or move are shown for that row.
Every Congress trade in WST, filterable by party, chamber, type and account.
Questions
Are insiders buying or selling WST?
Across the 6 most recent open-market filings shown here, 0 were purchases and 6 were sales. 3 were scheduled in advance under a Rule 10b5-1 plan.
Which members of Congress have traded WST?
Ro Khanna, Lisa C. McClain, Robert Bresnahan and Jared Moskowitz disclosed WST transactions in the filings shown here.
Is WST in the S&P 500 or the Nasdaq 100?
West Pharmaceutical Services, Inc. is a current member of the S&P 500, per the membership list we hold as of Oct 27, 2026. Current members of either index get a page here whatever their filing history.
How quickly are WST trades disclosed?
Insider filings on this page reached the public a median of 2 business days after the transaction (weekends and federal holidays skipped), against the two business days Form 4 allows. Congressional disclosures took a median of 30 days, against the 45 the STOCK Act allows.
How to read a Form 4
A DECISION THE INSIDER MADE
COMPENSATION PLUMBING
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Oct 27, 2026.